Myriam Heiman

Myriam Heiman

Auto-generated profile, based on publicly available information

Myriam Heiman

Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2014 in Nature Protocols
Verified
Journal Article
Open access
PDF file
MHMyriam Heiman
Myriam Heiman
RKRuth Kulicke
Ruth Kulicke
RFRobert J Fenster
Robert J Fenster
PGPaul Greengard
Paul Greengard
NHNathaniel Heintz
Nathaniel Heintz
Translating ribosome affinity purification (TRAP) combines cell type–specific transgene expression with affinity purification of translating ribosomes and can be used to study the cell type–specific mRNA profiles of any genetically defined cell type. Cellular diversity and architectural complexity create barriers to understanding the function of the mammalian CNS at a molecular level. To address this problem, we have recently developed a methodology that provides the ability to profile the entire translated mRNA complement of any genetically defined cell population. This methodology, which we termed translating ribosome affinity purification, or TRAP, combines cell type–specific transgene expression with affinity purification of translating ribosomes. TRAP can be used to study the cell type–specific mRNA profiles of any genetically defined cell type, and it has been used in organisms ranging from Drosophila melanogaster to mice and human cultured cells. Unlike other methodologies that rely on microdissection, cell panning or cell sorting, the TRAP methodology bypasses the need for tissue fixation or single-cell suspensions (and the potential artifacts that these treatments introduce) and reports on mRNAs in the entire cell body. This protocol provides a step-by-step guide to implement the TRAP methodology, which takes 2 d to complete once all materials are in hand.

14 February 2022 in Nature
Verified
Journal Article
Closed access
PDF file
FGFrancisco J. Garcia
Francisco J. Garcia
NSNa Sun
Na Sun
HLHyeseung Lee
Hyeseung Lee
BGBrianna Godlewski
Brianna Godlewski
HMHansruedi Mathys
Hansruedi Mathys
MHMyriam Heiman
Myriam Heiman

17 July 2020 in Neuron
Verified
Journal Article
Closed access
HLHyeseung Lee
Hyeseung Lee
RFRobert J. Fenster
Robert J. Fenster
SPS. Sebastian Pineda
S. Sebastian Pineda
WGWhitney S. Gibbs
Whitney S. Gibbs
SMShahin Mohammadi
Shahin Mohammadi
MHMyriam Heiman
Myriam Heiman

26 February 2025 in Nature
Verified
Journal Article
Open access
PDF file
SSSophia M. Shi
Sophia M. Shi
RSRyan J. Suh
Ryan J. Suh
DSD. Judy Shon
D. Judy Shon
FGFrancisco J. Garcia
Francisco J. Garcia
JBJosephine K. Buff
Josephine K. Buff
TWTony Wyss-Coray
Tony Wyss-Coray
The blood–brain barrier (BBB) is highly specialized to protect the brain from harmful circulating factors in the blood and maintain brain homeostasis1,2. The brain endothelial glycocalyx layer, a carbohydrate-rich meshwork composed primarily of proteoglycans, glycoproteins and glycolipids that coats the BBB lumen, is a key structural component of the BBB3,4. This layer forms the first interface between the blood and brain vasculature, yet little is known about its composition and roles in supporting BBB function in homeostatic and diseased states. Here we find that the brain endothelial glycocalyx is highly dysregulated during ageing and neurodegenerative disease. We identify significant perturbation in an underexplored class of densely O-glycosylated proteins known as mucin-domain glycoproteins. We demonstrate that ageing- and disease-associated aberrations in brain endothelial mucin-domain glycoproteins lead to dysregulated BBB function and, in severe cases, brain haemorrhaging in mice. Finally, we demonstrate that we can improve BBB function and reduce neuroinflammation and cognitive deficits in aged mice by restoring core 1 mucin-type O-glycans to the brain endothelium using adeno-associated viruses. Cumulatively, our findings provide a detailed compositional and structural mapping of the ageing brain endothelial glycocalyx layer and reveal important consequences of ageing- and disease-associated glycocalyx dysregulation on BBB integrity and brain health.

22 March 2024 in Cell
Verified
Journal Article
Closed access
SPS. Sebastian Pineda
S. Sebastian Pineda
HLHyeseung Lee
Hyeseung Lee
MUMaria J. Ulloa-Navas
Maria J. Ulloa-Navas
RLRaleigh M. Linville
Raleigh M. Linville
FGFrancisco J. Garcia
Francisco J. Garcia
MKManolis Kellis
Manolis Kellis

1 April 2020 in Neuron
Verified
Journal Article
Closed access
MWMary H. Wertz
Mary H. Wertz
MMMollie R. Mitchem
Mollie R. Mitchem
SPS. Sebastian Pineda
S. Sebastian Pineda
LHLea J. Hachigian
Lea J. Hachigian
HLHyeseung Lee
Hyeseung Lee
MHMyriam Heiman
Myriam Heiman